Heart failure & cardiomyopathies

Prospective systematic screening for transthyretin amyloid cardiomyopathy in cardiology inpatients with left ventricular hypertrophy: the IMPACT study

Eur Heart J Cardiovasc ImagingPublished prospective single-centre study

Authors' conclusion

In a minimally selected cardiology population with LVH, systematic screening identified a substantial prevalence of ATTR-CM. BLS may help prioritize diagnostic testing in routine practice and facilitate earlier identification and management of ATTR-CM.

Study context

Population
Consecutive patients aged ≥60 years hospitalized in cardiology with echocardiographic left ventricular hypertrophy (LVH) (wall thickness ≥12 mm), irrespective of aetiology; excluding known amyloidosis, prior heart transplantation, or contraindication to scintigraphypatients screened between October 2021 and June 2023
Participants
400 patients
Exposure
ATTR-CM vs non-ATTR-CM patients
  • ATTR-CMn = 29
Methodological detailsconsecutive patients, systematic screening
  • Consecutive patients
  • Systematic screening

Main finding

As reported in the abstract

Prevalence of ATTR-CM

ATTR-CM diagnosed

29 of 400 patients

7.3%

Observational data: associations, not effects.

Further findings

Variables independently associated with ATTR-CM (multivariable logistic regression)

ComparisonOR (95% CI)P value
Basal longitudinal strain (BLS)0.84 (0.74–0.95)
Non-sinus rhythm3.85 (1.30–11.11)
Bilateral carpal tunnel syndrome3.48 (1.09–11.14)
History of stroke8.67 (2.65–28.34)
OutcomeEstimateP value
All-cause mortality · median follow-up of 3.31 years · did not significantly differP = 0.137

Discrimination for ATTR-CM

Basal longitudinal strain (BLS) showed the highest discrimination for ATTR-CM (AUC)
0.81

Original publication

Prospective systematic screening for transthyretin amyloid cardiomyopathy in cardiology inpatients with left ventricular hypertrophy: the IMPACT study. Eur Heart J Cardiovasc Imaging. Published 15 September 2026. doi:10.1093/ehjci/jeag254

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.